The Walden Group is pleased to provide access to its 2024 Year-end Strategic Healthcare M&A Report which includes:
Significant M&A Deals by Sector - 2024
Top Deals > $100m in Transaction Value Announced or Closed in 2024
Performance of Leading Healthcare Companies
Analysis of More Than 30 Q4 M&A...
Read More
The Walden Group is pleased to announce that it represented RICA Surgical Products, Inc., as investment banker and M&A adviser, in its sale to Mastel Precision Surgical Instruments, Inc., a member of the Pacific Surgical family of companies (based primarily in Canada). RICA Surgical adds to Mastel Surgical an extensive range of...
Read More
The Walden Group is pleased to provide access to its Q2 Strategic Healthcare M&A Report, which includes:
Q2 2024 Market Developments
Noteworthy M&A Deals By Sector
Top Deals > $100m in Transaction Value Announced or Closed in Q2 2024
Performance of Leading Healthcare Companies
Analysis of More Than...
Read More
The Walden Group is pleased to provide access to its Strategic Healthcare M&A Report, which includes:
Q1 2024 Market Developments
Noteworthy M&A Deals By Sector
Top Deals > $100m in Transaction Value Announced or Closed in Q1 2024
Performance of Leading Healthcare Companies
Analysis of More Than 45...
Read More
The Walden Group is pleased to provide access to its 2023 Year-end Strategic Healthcare M&A Report which includes:
The Big Picture -- 2023 and What to Expect in 2024
Move-the-Needle M&A Deals by Sector - 2023 and YTD 2024
Insights from the CEOs
Top Deals > $100m in Transaction Value Announced or Closed...
Read More